How should I diagnose and manage a 38‑year‑old obese woman (BMI 31.7 kg/m²) with a history of gestational diabetes, acanthosis nigricans, fasting glucose 98 mg/dL, 2‑hour post‑prandial glucose 145 mg/dL, HbA1c 6.6 % and dyslipidemia (total cholesterol 220 mg/dL, LDL 140 mg/dL, HDL 38 mg/dL, triglycerides 180 mg/dL), and is she fit for work?

Diagnosis: Type 2 Diabetes with Dyslipidemia and Metabolic Syndrome

This patient has type 2 diabetes, not prediabetes, based on her HbA1c of 6.6% (diagnostic threshold ≥6.5%), and requires immediate pharmacologic intervention with metformin plus intensive lifestyle modification. 1

Diagnostic Confirmation

Current Diabetes Status

• HbA1c 6.6% meets diagnostic criteria for type 2 diabetes (≥6.5% threshold), confirmed by a single test in the presence of classic symptoms (polydipsia, fatigue, paresthesias, polyuria) 1
• Fasting glucose 98 mg/dL is below the diabetes threshold (≥126 mg/dL) but her 2-hour postprandial of 145 mg/dL approaches impaired glucose tolerance (≥200 mg/dL for diabetes) 1
• No repeat testing is required given the presence of unequivocal hyperglycemic symptoms (increased thirst, fatigue, leg cramps, tingling, increased urination) 1

High-Risk Features Present

• History of gestational diabetes 5 years ago places her at 50-60% cumulative lifetime risk for type 2 diabetes 1
• Acanthosis nigricans (dark velvety patches on neck/underarms) indicates severe insulin resistance and is associated with 5.5-fold increased risk of diabetes 1, 2
• BMI 31.7 kg/m² (Class II obesity) with central adiposity (waist circumference 84 cm, WHR 0.88) 1
• Strong family history: mother with type 2 diabetes, father died of MI at age 62 1

Metabolic Syndrome and Cardiovascular Risk

Dyslipidemia Profile

This patient meets criteria for atherogenic dyslipidemia requiring treatment: 1

• Total cholesterol 220 mg/dL (elevated, goal <200 mg/dL)
• LDL 140 mg/dL (significantly elevated, goal <100 mg/dL for diabetes)
• HDL 38 mg/dL (low, goal >50 mg/dL for women)
• Triglycerides 180 mg/dL (elevated, goal <150 mg/dL)
• TG:HDL ratio = 4.7 (highly atherogenic, goal <3.0) 3

Blood Pressure

• 130/80 mmHg meets hypertension criteria (≥130/80 mmHg threshold for diabetes) and requires treatment 1

Metabolic Syndrome Diagnosis

She meets 5 of 5 criteria for metabolic syndrome: 1

1. Waist circumference 84 cm (≥88 cm threshold for women is nearly met; WHR 0.88 indicates central obesity)
2. Triglycerides 180 mg/dL (≥150 mg/dL)
3. HDL 38 mg/dL (<50 mg/dL for women)
4. Blood pressure 130/80 mmHg (≥130/85 mmHg)
5. Fasting glucose 98 mg/dL (≥100 mg/dL threshold nearly met; HbA1c 6.6% confirms diabetes)

Management Plan

Immediate Pharmacologic Therapy

Metformin 500-850 mg once daily with dinner, titrate to 2000 mg daily over 4-6 weeks is the first-line medication: 1

• Strongly indicated given BMI >35 kg/m², history of GDM, and HbA1c 6.6% 1
• In the Diabetes Prevention Program, metformin reduced diabetes progression by 40% over 10 years in women with prior GDM 1
• Cost-effective and potentially cost-saving over 10 years 1
• Start with evening dose to minimize GI side effects; titrate based on tolerance

Intensive Lifestyle Modification (Mandatory, Not Optional)

Structured weight loss program targeting 7% body weight reduction (5.5 kg from 78 kg to 73 kg): 1

• ≥150 minutes per week of moderate-intensity physical activity (e.g., brisk walking 30 minutes, 5 days/week) 1
• Medical nutrition therapy with registered dietitian: minimum 175 g carbohydrate, 71 g protein, 28 g fiber daily; focus on reducing fast food consumption and irregular meal schedules 1
• Ongoing support program with follow-up counseling is critical for success 1
• In the Diabetes Prevention Program, lifestyle modification was more effective than metformin (58% vs 31% risk reduction) but combining both is optimal for her risk profile 1

Lipid Management

Initiate moderate-intensity statin therapy immediately: 1

• Atorvastatin 10-20 mg daily or rosuvastatin 5-10 mg daily
• Target LDL <100 mg/dL (ideally <70 mg/dL given diabetes and family history of premature CAD) 1
• Recheck lipid panel in 6-8 weeks after statin initiation

Blood Pressure Management

Initiate ACE inhibitor or ARB if not planning immediate pregnancy: 1

• Lisinopril 10 mg daily or losartan 50 mg daily
• Target BP <130/80 mmHg 1
• Critical caveat: ACE inhibitors and ARBs are teratogenic and must be stopped immediately if pregnancy is planned or occurs 1
• If pregnancy is planned within 6 months, consider alternative agents (labetalol, nifedipine)

Monitoring Schedule

Quarterly follow-up for the first year: 1

• HbA1c every 3 months until target <7.0% achieved, then every 6 months 1
• Fasting lipid panel at 6-8 weeks after statin initiation, then annually 1
• Blood pressure at every visit 1
• Liver function tests at baseline and periodically on statin therapy 1
• Annual screening for diabetes complications: comprehensive foot exam, urine albumin-to-creatinine ratio, dilated eye exam 1

Postpartum GDM Follow-Up (Overdue)

She should have been screened 6-12 weeks postpartum 5 years ago but was not: 1

• Current testing now confirms progression to type 2 diabetes 1
• Lifelong screening every 1-3 years was indicated after GDM diagnosis 1
• Her current presentation represents a 5-year delay in diagnosis, during which microvascular complications may have begun

Fitness for Work Determination

She is FIT FOR WORK with the following conditions:

1. Diabetes is newly diagnosed but not causing acute complications (no DKA, HHS, severe hypoglycemia risk) 1
2. Blood pressure 130/80 mmHg is controlled and not causing end-organ damage 1
3. No evidence of advanced complications: no retinopathy symptoms, no foot ulcers, no cardiovascular symptoms 1
4. Neurologic symptoms (leg cramps, tingling) are mild peripheral neuropathy that does not impair function 1

Work Restrictions and Accommodations

• No restrictions on sedentary work (call center agent role is appropriate) 1
• Recommend regular breaks for physical activity (5-10 minutes every 2 hours to walk) 1
• Encourage healthy meal planning despite irregular work schedule 1
• Re-evaluate fitness if hypoglycemia occurs after starting metformin (rare but possible) 1

Preconception Counseling (Critical for Future Pregnancies)

If she plans future pregnancies, preconception optimization is mandatory: 1

• Target HbA1c <6.5% (ideally <6.0%) before conception to reduce congenital malformation risk 1
• Stop ACE inhibitor/ARB and switch to methyldopa or labetalol for BP control 1
• Continue metformin through conception and pregnancy (safe and effective) 1
• Folic acid 400-800 mcg daily starting 3 months before conception 1
• Low-dose aspirin 100-162 mg daily starting at 12-16 weeks gestation to reduce preeclampsia risk 1

Common Pitfalls to Avoid

1. Do not delay treatment by labeling this as "prediabetes"—HbA1c 6.6% is diagnostic for diabetes 1
2. Do not rely on lifestyle modification alone—metformin is indicated given her BMI >35 kg/m², prior GDM, and HbA1c 6.6% 1
3. Do not miss the dyslipidemia—statin therapy is mandatory for cardiovascular risk reduction 1
4. Do not forget contraception counseling—unplanned pregnancy with HbA1c 6.6% carries high teratogenic risk 1
5. Do not overlook acanthosis nigricans—this indicates severe insulin resistance and warrants aggressive metabolic intervention 1, 2
6. Do not use glyburide or sulfonylureas—these are inappropriate first-line agents and carry hypoglycemia risk 1